Cargando…
Retraction: MiR-22 inhibition alleviates cardiac dysfunction in doxorubicin-induced cardiomyopathy by targeting the sirt1/PGC-1α pathway
Autor principal: | Frontiers Editorial Office |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450219/ https://www.ncbi.nlm.nih.gov/pubmed/36091381 http://dx.doi.org/10.3389/fphys.2022.1020568 |
Ejemplares similares
-
MiR-22 Inhibition Alleviates Cardiac Dysfunction in Doxorubicin-Induced Cardiomyopathy by Targeting the sirt1/PGC-1α Pathway
por: Wang, Runze, et al.
Publicado: (2021) -
Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy
por: Wang, Runze, et al.
Publicado: (2021) -
Retraction: NEAT1 Overexpression Indicates a Poor Prognosis and Induces Chemotherapy Resistance via the miR-491-5p/SOX3 Signaling Pathway in Ovarian Cancer
por: Frontiers Editorial Office,
Publicado: (2022) -
Retraction: Long noncoding RNA SNHG1 activates autophagy and promotes cell invasion in bladder cancer
por: Office, Frontiers Editorial
Publicado: (2023) -
Erratum: Hypertrophic cardiomyopathy: Mutations to mechanisms to therapies
por: Frontiers Production Office,
Publicado: (2022)